Universal Health Services Inc. (NYSE:UHS) shares traded higher over the last trading session, gaining 0.25% on 05/26/21. The shares fell to a low of $159.27 before closing at $160.15. Intraday shares traded counted 1.53 million, which was -149.9% lower than its 30-day average trading volume of 611.25K. UHS’s previous close was $159.75 while the outstanding shares total 84.78M. The firm has a beta of 1.20, a 12-month trailing P/E ratio of 13.57, and a growth ratio of 1.91. The stock’s Relative Strength Index (RSI) is 69.83, with weekly volatility at 1.76% and ATR at 3.16. The UHS stock’s 52-week price range has touched low of $86.67 and a $161.60 high.
Investors have identified the Medical Care Facilities company Universal Health Services Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $13.65 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Universal Health Services Inc. (UHS) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For UHS, the company has in raw cash 764.5 million on their books with 107.28 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 2.78 billion total, with 2.24 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 12.28 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on UHS sounds very interesting.
Is the stock of UHS attractive?
In related news, Director, SUSSMAN ELLIOT J MD MBA sold 2,553 shares of the company’s stock in a transaction that recorded on May 10. The sale was performed at an average price of 157.88, for a total value of 403,068. As the sale deal closes, the Director, McDonnell Eileen C. now sold 3,660 shares of the company’s stock, valued at 570,535. Also, Executive Vice President, UHS, Peterson Matthew Jay sold 5,122 shares of the company’s stock in a deal that was recorded on Apr 29. The shares were price at an average price of 149.82 per share, with a total market value of 767,360. Following this completion of acquisition, the Director, McDonnell Eileen C. now holds 2,483 shares of the company’s stock, valued at 368,552. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.30%.